Browsing by Yonsei Author : Kim, Chang Gon

eperson profile image
Name:
Kim, Chang Gon [김창곤]
Department :
College of Medicine (의과대학) - Dept. of Internal Medicine (내과학교실)

Keyword Cloud

Researcher Network

Showing results 1 to 22 of 22

This table browses all dspace content
Issue DateTitleJournal Title
2023Atezolizumab plus bevacizumab in patients with child–Pugh B advanced hepatocellular carcinoma THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY
2022YH29407 with anti-PD-1 ameliorates anti-tumor effects via increased T cell functionality and antigen presenting machinery in the tumor microenvironment FRONTIERS IN CHEMISTRY
2022Hyperprogressive disease during PD-1 blockade in patients with advanced gastric cancerEUROPEAN JOURNAL OF CANCER
2022Phase II Clinical Trial of Eribulin-Gemcitabine Combination Therapy in Previously Treated Patients With Advanced Liposarcoma or LeiomyosarcomaCLINICAL CANCER RESEARCH
2022The presence and size of intrahepatic tumors determine the therapeutic efficacy of nivolumab in advanced hepatocellular carcinoma THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY
2022Disproportional enrichment of FoxP3(+)CD4(+) regulatory T cells shapes a suppressive tumourmicroenvironment in head and neck squamous cell carcinoma CLINICAL AND TRANSLATIONAL MEDICINE
2022The Development of AXL Inhibitors in Lung Cancer: Recent Progress and Challenges FRONTIERS IN ONCOLOGY
2022SKI-G-801, an AXL kinase inhibitor, blocks metastasis through inducing anti-tumor immune responses and potentiates anti-PD-1 therapy in mouse cancer models CLINICAL & TRANSLATIONAL IMMUNOLOGY
2022Primary Tumor Suppression and Systemic Immune Activation of Macrophages through the Sting Pathway in Metastatic Skin Tumor YONSEI MEDICAL JOURNAL
2022Antibody-Drug Conjugates: A New Addition to the Treatment Landscape of EGFR-Mutant Non-Small Cell Lung CancerCANCER RESEARCH
2022Patritumab Deruxtecan: Paving the Way for EGFR-TKI-Resistant NSCLCCANCER DISCOVERY
2022Predicting treatment outcomes using 18 F-FDG PET biomarkers in patients with non-small-cell lung cancer receiving chemoimmunotherapy THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY
2021Distinct exhaustion features of T lymphocytes shape the tumor-immune microenvironment with therapeutic implication in patients with non-small-cell lung cancer JOURNAL FOR IMMUNOTHERAPY OF CANCER
2021Modeling Clinical Responses to Targeted Therapies by Patient-Derived Organoids of Advanced Lung Adenocarcinoma CLINICAL CANCER RESEARCH
2021Clinical decision support algorithm based on machine learning to assess the clinical response to anti-programmed death-1 therapy in patients with non-small-cell lung cancerEUROPEAN JOURNAL OF CANCER
2021Combining Cancer Vaccines with Immunotherapy: Establishing a New Immunological ApproachINTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
2021Sequencing of MET Inhibitors in Lung Cancer: Have We Met the Target?JOURNAL OF THORACIC ONCOLOGY
2021Adaptive Natural Killer Cells Facilitate Effector Functions of Daratumumab in Multiple MyelomaCLINICAL CANCER RESEARCH
2021PD-1 blockade-unresponsive human tumor-infiltrating CD8 + T cells are marked by loss of CD28 expression and rescued by IL-15CELLULAR & MOLECULAR IMMUNOLOGY
2021Hyperprogressive disease during PD-1 blockade in patients with advanced hepatocellular carcinomaJOURNAL OF HEPATOLOGY
2021Dynamic changes in circulating PD-1(+)CD8(+)T lymphocytes for predicting treatment response to PD-1 blockade in patients with non-small-cell lung cancerEUROPEAN JOURNAL OF CANCER
2020Clinical Significance of Preoperative Serum Carcinoembryonic Antigen Within the Normal Range in Colorectal Cancer Patients Undergoing Curative ResectionANNALS OF SURGICAL ONCOLOGY
1

Browse

Links